CD8A and neoplasm: This suggests that although far more NeoAg-specific CD8 T cells are observed within tumors treated with neo VAX as compared to control VAX (Figures 3C and 3D), within NeoAg-specific CD8 T cells, both control VAX and neo VAX promotes cycling tumor-specific CD8 T cells.